Spyre Therapeutics (SYRE) Stock News
$SYRE · NASDAQ · 4 stories in 30 days$79.99
1D −0.14%1W +0.42%1M −11.40%
BORSA has published 4 stories on Spyre Therapeutics (SYRE) in the past 30 days. BORSA’s news read on SYRE is bullish at 66/100, unchanged over 24 hours, based on 2 company events over the past 7 days. SYRE last closed at $80.45 on Oct 13, up 0.42% over five sessions and down 11.40% over the past month. Spyre Therapeutics’ next earnings report is scheduled for Tuesday, Nov 3.
The wire on $SYRE
newest first · updated · direct subject stories onlyUBS sets $120.00 price target for Spyre Therapeutics
UBS issued a new price target of $120.00 for Spyre Therapeutics shares.
neutral 50 · impact 30
